Oncology Therapeutics Market in India to 2018 Report
DUBLIN, Ireland, August 9, 2013 /PRNewswire/ –
Research and Markets (http://www.researchandmarkets.com/research/lxh575/oncology)
has announced the addition of the “Oncology Therapeutics Market in India to 2018 -
Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among
Domestic and Multinational Players”
[http://www.researchandmarkets.com/research/lxh575/oncology ] report to their offering.
GBI Research, the leading business intelligence provider, has released its latest
research, “”Oncology Therapeutics Market in India to 2018 – Introduction of Market-Based
Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational
Players”", which provides in-depth analysis of the key therapeutic indications of
oncology, breast cancer, colorectal cancer, prostate cancer, lung cancer and Non-Hodgkin’s
Lymphoma (NHL), with forecasts until 2018. It also looks at treatment usage patterns and
includes insights into the oncology R&D pipeline.
The Indian oncology therapeutics market for breast cancer, lung cancer, colorectal
cancer, prostate cancer and NHL was estimated to be worth $153.3m in 2011, having grown at
a Compound Annual Growth Rate (CAGR) of 12.7% from 2004. It is expected to reach $238.8m
in 2018 at a CAGR of 6.5% from 2011. The slower growth in the forecast period is mainly
due to the reduction in the price of leading marketed products for breast cancer,
colorectal cancer, lung cancer and NHL after all 348 drugs on the National List of
Essential Medicines (NLEM) are brought under price control regulations.
The limitations of the current market are unclear patent laws, restrictive pricing and
reimbursement policies, ailing infrastructure, and insufficient government aid. Low
patient affordability is also a major restraint, and one that reimbursement and insurance
policies must address if the market is to develop in the future.
– The report analyzes treatment usage patterns, market characterization, pipeline
analysis, competitive landscape and key M&A trends in the breast cancer, colorectal
cancer, prostate cancer, lung cancer and NHL markets.
– Data and analysis for the oncology therapeutics market in India
– Annualized market data for the oncology therapeutics market in India from 2004 to
2011, with forecasts to 2018
– Key drivers and restraints that have had a significant impact on the market
– The competitive landscape of the oncology therapeutics
[http://www.researchandmarkets.com/research/lxh575/oncology ] market in India
– Key M&A activities and licensing agreements that have taken place in the Indian
oncology therapeutics market
- Dr. Reddy’s Laboratories
- Natco Pharma
For more information visit
About Research and Markets
Research and Markets is the world’s leading source for international market research
reports and market data. We provide you with the latest data on international and regional
markets, key industries, the top companies, new products and the latest trends.
Research and Markets Laura Wood, Senior Manager. email@example.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices [http://www.researchandmarkets.com/categories.asp?cat_id=12&campaign_id=lxh575 ]
SOURCE Research and Markets